State Street Corp Soleno Therapeutics Inc Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.22 - $0.47 $2,561 - $5,471	11,641 Added 5.29%	231,741 $52,000
Q2 2021 Aug 16, 2021	SELL	$0.97 - $1.32 $607,498 - $826,698	-626,287 Reduced 74.0%	220,100 $251,000
Q1 2021 May 17, 2021	BUY	$1.24 - $3.3 $155,000 - $412,500	125,000 Added 17.33%	846,387 $1.07 Million
Q4 2020 Feb 16, 2021	BUY	$1.61 - $2.23 $541,050 - $749,404	336,056 Added 87.21%	721,387 $1.39 Million
Q3 2020 Nov 10, 2020	BUY	$1.71 - $2.51 $147,865 - $217,042	86,471 Added 28.93%	385,331 $967,000
Q2 2020 Aug 14, 2020	BUY	$1.77 - $4.23 $528,982 - $1.26 Million	298,860 New	298,860 $663,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $362M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.